Literature DB >> 6091139

Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.

T Kiyokawa, H Yoshikura, S Hattori, M Seiki, M Yoshida.   

Abstract

The DNA fragments of the 5' and 3' halves of the putative env gene predicted from the DNA sequence of human T-cell leukemia virus (HTLV) provirus were inserted into expression vectors pORF2 and pORF1, respectively, and two hybrid proteins composed of env polypeptides and beta-galactosidase were efficiently produced in Escherichia coli. The hybrid proteins containing the NH2-terminal (EH9) and COOH-terminal (EA1) halves were both immunologically reactive with sera from adult T-cell leukemia patients, demonstrating the utility of the hybrid proteins for diagnosis of HTLV infection. Rabbit antisera against these hybrid proteins detected the two glycoproteins gp62 and gp46, which were previously identified as HTLV env gene products. With these rabbit antisera, two properties of the env gene products were studied. (i) The antisera inhibited syncytia formation of cat S+L- cells induced by HTLV, suggesting that one or both of the env gene products of HTLV, gp62 and gp46, are involved in induction of cell fusion. (ii) The env product gp62 or gp46 or both products are exposed on the surface of HTLV-infected cells and might modulate the proliferation of HTLV-infected T cells in the host because the antisera against the hybrid proteins were cytotoxic on HTLV-producing cell lines. The latter conclusion also is supported by the fact that adult T-cell leukemia patients and healthy HTLV carriers have antibodies to the env gene products.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091139      PMCID: PMC391888          DOI: 10.1073/pnas.81.19.6202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes.

Authors:  O N Witte; A Tsukamoto-Adey; I L Weissman
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

3.  Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71.

Authors:  J DeLarco; G J Todaro
Journal:  Cell       Date:  1976-07       Impact factor: 41.582

4.  Isolation of RD-114-like oncornavirus from a cat cell line.

Authors:  P J Fischinger; P T Peebles; S Nomura; D K Haapala
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies.

Authors:  M R Stone; R C Nowinski
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

7.  Characterization of a new human diploid cell strain, IMR-90.

Authors:  W W Nichols; D G Murphy; V J Cristofalo; L H Toji; A E Greene; S A Dwight
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

8.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Properties of an oncornavirus glycoprotein: evidence for its presence on the surface of virions and infected cells.

Authors:  S J Kennel; B C Del Villano; R L Levy; R A Lerner
Journal:  Virology       Date:  1973-10       Impact factor: 3.616

10.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  17 in total

1.  Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.

Authors:  K G Hadlock; J Rowe; S Perkins; P Bradshaw; G Y Song; C Cheng; J Yang; R Gascon; J Halmos; S M Rehman; M S McGrath; S K Foung
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Authors:  A R Rosenberg; L Delamarre; C Pique; D Pham; M C Dokhélar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.

Authors:  J Arp; M LeVatte; J Rowe; S Perkins; E King; C Leystra-Lantz; S K Foung; G A Dekaban
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.

Authors:  Ayse Kubra Coskun; Richard E Sutton
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people.

Authors:  Y M Chen; T H Lee; K P Samuel; A Okayama; N Tachibana; I Miyoshi; T S Papas; M Essex
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Type 1 human T-cell leukemia virus small envelope protein expressed in mouse cells by using a bovine papilloma virus-derived shuttle vector.

Authors:  M Eiden; M Newman; A G Fisher; D L Mann; P M Howley; M S Reitz
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

Review 7.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

8.  Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Authors:  Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.

Authors:  Y Sagara; Y Inoue; H Shiraki; A Jinno; H Hoshino; Y Maeda
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

10.  Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.

Authors:  K Fukudome; M Furuse; T Imai; M Nishimura; S Takagi; Y Hinuma; O Yoshie
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.